Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-23

Clinical Trial Update: Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of gabapentin enacarbil on arousals, heart rate, blood pressure, and periodic limb movements in patients with restless legs…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • gabapentin enacarbil (gabapentin enacarbil)

Snippet

Sponsor: Cleveland Sleep Research Center | Conditions: Restless Legs Syndrome | Phase 4 | Status: UNKNOWN